Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
FOX 13's Allie Corey sat down with the chief of surgical oncology at TGH Institute and professor of surgery at USF Health as ...
A study published in the November issue of Redox Biology has found that adding intravenous, high-dose vitamin C to a ...
The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small ...
There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
Dec 2 (Reuters) - Novocure (NVCR.O), opens new tab said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy ...
Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...
This morning, dealing with it after it develops and becomes a real threat. One key treatment option is called the Whipple ...
Using tumor-treating fields alongside chemotherapy improved patient survival, Novocure said. Elsewhere, Cytokinetics got a ...
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.